SLC9A1 and colon carcinoma: Both the activity and the expression of NHE1 are increased also in doxorubicin-resistant (HT29-dx) human colon carcinoma cells suggesting a role for NHE1 in the development of multidrug resistance in tumor cells (Miraglia et al., 2005).